Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancer

BACKGROUND: The prognosis of recurrent and unresectable gastric cancer remains poor despite the development of multidisciplinary treatments. Ramucirumab (RAM) has been proven effective against unresectable or recurrent gastric cancer. However, its administration is often discontinued because of adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Uehata, Naoyuki, Kouzu, Keita, Tsujimoto, Hironori, Sugasawa, Hidekazu, Wakamatsu, Kotaro, Kishi, Yoji, Ueno, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055802/
https://www.ncbi.nlm.nih.gov/pubmed/33876326
http://dx.doi.org/10.1186/s40792-021-01185-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055802/
https://www.ncbi.nlm.nih.gov/pubmed/33876326
http://dx.doi.org/10.1186/s40792-021-01185-9

Ejemplares similares